I never once said Covid was over. Simply that’s it’s not what it was. And the further out this gets with no product to market, the less impact that kind of catalyst is going to have here than it did before.
I do think the only possible catalyst that could see us finally back over .25-.50 anytime in the next year would be if the Regeneron Covid mab speculation turns out to be us. And part of the reason for that is due to the fact that would surely get us some national exposure here in the states at least. And most likely international exposure as well.
If the Regeneron Covid thing isn’t us, I really don’t see anything else coming anytime soon that would be moving us up past the recent highs in the teens.
Market Data 
Markets 
AI
